Published in J Clin Diagn Res on November 20, 2014
Relationship between Periodontitis and Rheumatoid Arthritis: Review of the Literature. Mediators Inflamm (2015) 0.81
RANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model. Front Physiol (2017) 0.75
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Problems and proposals for recording gingivitis and plaque. Int Dent J (1975) 5.75
Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 (2004) 2.57
Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis (2002) 1.79
Host response modulation in the management of periodontal diseases. J Clin Periodontol (2005) 1.47
Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 (2007) 1.44
Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol (2003) 1.12
Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res (2003) 1.11
Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000 (2007) 1.06
Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males. Clin Endocrinol (Oxf) (2005) 1.00
Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth. Eur J Oral Sci (2003) 1.00
Immunohistochemical localization of receptor activator of nuclear factor kappaB (RANK) and its ligand (RANKL) in human deciduous teeth. Calcif Tissue Int (2002) 0.98
Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res (2006) 0.96
Clinical applications of RANK-ligand inhibition. Intern Med J (2009) 0.90
High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes. J Periodontol (2006) 0.88
RANKL/RANK/OPG: key therapeutic target in bone oncology. Curr Drug Discov Technol (2008) 0.87
Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol (2004) 0.87